Desialylated Platelet Clearance in the Liver is a Novel Mechanism of Systemic Immunosuppression.

June Li, Danielle Karakas, Feng Xue, Yingyu Chen, Guangheng Zhu, Yeni H Yucel, Sonya A MacParland, Haibo Zhang, John W Semple, John Freedman, Qizhen Shi, Heyu Ni
Author Information
  1. June Li: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  2. Danielle Karakas: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  3. Feng Xue: Departments of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
  4. Yingyu Chen: Departments of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
  5. Guangheng Zhu: Toronto Platelet Immunobiology Group, Toronto, ON, Canada.
  6. Yeni H Yucel: Keenan Research Centre for Biomedical Science of St. Michael's Hospital, Toronto, ON, Canada.
  7. Sonya A MacParland: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  8. Haibo Zhang: Keenan Research Centre for Biomedical Science of St. Michael's Hospital, Toronto, ON, Canada.
  9. John W Semple: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  10. John Freedman: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  11. Qizhen Shi: Departments of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
  12. Heyu Ni: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. ORCID

Abstract

Platelets are small, versatile blood cells that are critical for hemostasis/thrombosis. Local platelet accumulation is a known contributor to proinflammation in various disease states. However, the anti-inflammatory/immunosuppressive potential of platelets has been poorly explored. Here, we uncovered, unexpectedly, desialylated platelets (dPLTs) down-regulated immune responses against both platelet-associated and -independent antigen challenges. Utilizing multispectral photoacoustic tomography, we tracked dPLT trafficking to gut vasculature and an exclusive Kupffer cell-mediated dPLT clearance in the liver, a process that we identified to be synergistically dependent on platelet glycoprotein Ibα and hepatic Ashwell-Morell receptor. Mechanistically, Kupffer cell clearance of dPLT potentiated a systemic immunosuppressive state with increased anti-inflammatory cytokines and circulating CD4 regulatory T cells, abolishable by Kupffer cell depletion. Last, in a clinically relevant model of hemophilia A, presensitization with dPLT attenuated anti-factor VIII antibody production after factor VIII ( infusion. As platelet desialylation commonly occurs in daily-aged and activated platelets, these findings open new avenues toward understanding immune homeostasis and potentiate the therapeutic potential of dPLT and engineered dPLT transfusions in controlling autoimmune and alloimmune diseases.

References

  1. Blood. 2018 Apr 5;131(14):1512-1521 [PMID: 29475962]
  2. Nat Rev Rheumatol. 2018 Mar 21;14(4):195-213 [PMID: 29559714]
  3. Blood. 2010 Nov 25;116(22):4639-45 [PMID: 20688957]
  4. Research (Wash D C). 2022 Jul 19;2022:9826426 [PMID: 35966759]
  5. Blood. 2014 May 1;123(18):2759-67 [PMID: 24585776]
  6. Nature. 1969 Aug 2;223(5205):472-6 [PMID: 4894426]
  7. J Thromb Haemost. 2020 Nov;18(11):2823-2825 [PMID: 33463084]
  8. Nat Genet. 1995 May;10(1):119-21 [PMID: 7647782]
  9. Research (Wash D C). 2022 Jul 16;2022:9794235 [PMID: 35958106]
  10. J Thromb Haemost. 2014 Apr;12(4):497-504 [PMID: 24517219]
  11. Science. 2010 Jan 29;327(5965):580-3 [PMID: 20110505]
  12. Research (Wash D C). 2023 Apr 24;6:0124 [PMID: 37223472]
  13. Hepatology. 2009 Aug;50(2):612-21 [PMID: 19575456]
  14. Int J Mol Sci. 2021 Mar 26;22(7): [PMID: 33810246]
  15. Blood. 2008 Oct 1;112(7):2713-21 [PMID: 18495954]
  16. Nat Commun. 2018 Sep 6;9(1):3608 [PMID: 30190457]
  17. Thromb Res. 2016 May;141 Suppl 2:S68-72 [PMID: 27207430]
  18. Cardiovasc Hematol Disord Drug Targets. 2013 Mar 1;13(1):50-8 [PMID: 23082940]
  19. Immunity. 2021 Sep 14;54(9):2101-2116.e6 [PMID: 34469775]
  20. Hepatology. 2015 Jul;62(1):279-91 [PMID: 25810240]
  21. Front Immunol. 2015 Sep 22;6:480 [PMID: 26441984]
  22. Curr Opin Hematol. 2018 Sep;25(5):373-381 [PMID: 30015642]
  23. J Hematol Oncol. 2017 May 11;10(1):104 [PMID: 28494777]
  24. Nat Med. 2011 Nov 07;17(11):1423-36 [PMID: 22064432]
  25. Pflugers Arch. 2017 Apr;469(3-4):561-572 [PMID: 28289977]
  26. EBioMedicine. 2022 Feb;76:103820 [PMID: 35074629]
  27. Lancet. 2016 Dec 3;388(10061):2825-2836 [PMID: 27083327]
  28. J Thromb Haemost. 2009 Nov;7(11):1759-66 [PMID: 19691483]
  29. J Clin Invest. 1999 Jan;103(2):229-38 [PMID: 9916135]
  30. J Clin Invest. 2011 Nov;121(11):4537-47 [PMID: 22019589]
  31. Platelets. 2016 Sep;27(6):505-11 [PMID: 27135356]
  32. Blood. 2005 May 1;105(9):3577-82 [PMID: 15665111]
  33. Thromb Haemost. 2000 Nov;84(5):826-32 [PMID: 11127864]
  34. Chem Commun (Camb). 2017 Apr 25;53(34):4653-4672 [PMID: 28387781]
  35. Curr Opin Hematol. 2012 Nov;19(6):469-74 [PMID: 22954726]
  36. Blood. 2016 Mar 10;127(10):1346-54 [PMID: 26668132]
  37. J Clin Invest. 2006 Jul;116(7):1974-82 [PMID: 16823491]
  38. Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8360-8365 [PMID: 28716912]
  39. Int J Hematol. 2020 Aug;112(2):159-168 [PMID: 32476083]
  40. Nat Med. 2009 Nov;15(11):1273-80 [PMID: 19783995]
  41. Blood. 2002 Sep 15;100(6):2102-7 [PMID: 12200373]
  42. Am J Hematol. 2015 May;90(5):E94-5 [PMID: 25615710]
  43. Transfusion. 2008 Sep;48(9):1778-86 [PMID: 18522705]
  44. J Immunol. 2014 Jul 1;193(1):344-53 [PMID: 24890723]
  45. Nat Commun. 2015 Jul 17;6:7737 [PMID: 26185093]
  46. Photoacoustics. 2018 Aug 03;11:36-45 [PMID: 30105205]
  47. Lancet Haematol. 2021 Apr;8(4):e289-e298 [PMID: 33770484]
  48. Immunity. 2003 Jul;19(1):9-19 [PMID: 12871635]
  49. Nat Mater. 2016 Nov;15(11):1212-1221 [PMID: 27525571]
  50. Blood. 2008 Aug 15;112(4):1147-50 [PMID: 18375792]
  51. Semin Fetal Neonatal Med. 2016 Feb;21(1):19-27 [PMID: 26810319]
  52. Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20218-23 [PMID: 24284176]
  53. Can J Gastroenterol Hepatol. 2017;2017:2896809 [PMID: 28804705]
  54. J Clin Invest. 1995 Jul;96(1):447-55 [PMID: 7615817]
  55. Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):3329-34 [PMID: 26941238]
  56. Platelets. 2019;30(6):743-751 [PMID: 30296193]
  57. Nat Rev Immunol. 2011 Apr;11(4):264-74 [PMID: 21436837]
  58. Eur J Immunol. 2010 Jan;40(1):117-23 [PMID: 19877019]
  59. Blood. 2018 Aug 9;132(6):622-634 [PMID: 29794068]
  60. Transfus Med Rev. 2020 Oct;34(4):227-233 [PMID: 33036839]
  61. Blood. 2020 Feb 13;135(7):472-490 [PMID: 31756253]
  62. Blood. 2012 Feb 2;119(5):1263-73 [PMID: 22101895]
  63. J Thromb Haemost. 2015 Dec;13(12):2210-9 [PMID: 26453193]
  64. Transfus Med Rev. 2020 Oct;34(4):209-220 [PMID: 33051111]
  65. J Invest Dermatol. 2010 Feb;130(2):576-86 [PMID: 19727118]
  66. Photoacoustics. 2021 Jan 08;21:100239 [PMID: 33520651]
  67. J Cell Biol. 1998 Nov 16;143(4):1129-41 [PMID: 9817767]
  68. Nat Commun. 2018 Oct 22;9(1):4383 [PMID: 30348985]
  69. Front Immunol. 2020 Aug 07;11:1962 [PMID: 32849656]
  70. Nat Med. 2015 Jan;21(1):47-54 [PMID: 25485912]
  71. J Biol Chem. 2010 Jun 18;285(25):19193-204 [PMID: 20304916]
  72. J Autoimmun. 2010 Feb;34(1):1-6 [PMID: 19717280]
  73. Presse Med. 2016 Jul-Aug;45(7-8 Pt 2):e313-24 [PMID: 27499223]
  74. J Clin Med. 2020 Mar 17;9(3): [PMID: 32192039]
  75. Research (Wash D C). 2019 May 19;2019:5341375 [PMID: 31549066]
  76. J Hematol Oncol. 2017 Feb 8;10(1):46 [PMID: 28179000]
  77. Blood. 2009 Jul 9;114(2):425-36 [PMID: 19332769]
  78. Comp Hepatol. 2002 Aug 23;1(1):1 [PMID: 12437787]
  79. Am J Hematol. 2012 Feb;87(2):206-8 [PMID: 22139961]
  80. Blood. 2015 Jul 9;126(2):247-56 [PMID: 26036802]
  81. Sci Rep. 2016 Jun 20;6:27445 [PMID: 27321376]
  82. J Thromb Haemost. 2012 Aug;10(8):1570-80 [PMID: 22632092]
  83. Research (Wash D C). 2022 Jan 17;2022:9845459 [PMID: 35118420]
  84. Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2803-8 [PMID: 10706630]
  85. Front Immunol. 2019 Jul 17;10:1687 [PMID: 31379873]
  86. Crit Rev Clin Lab Sci. 2016 Dec;53(6):409-30 [PMID: 27282765]
  87. Res Pract Thromb Haemost. 2021 May 03;5(4):e12506 [PMID: 33977209]
  88. Blood. 2002 Aug 15;100(4):1340-6 [PMID: 12149216]
  89. Exp Cell Res. 1986 Aug;165(2):494-506 [PMID: 3013664]
  90. Ther Adv Hematol. 2013 Feb;4(1):59-72 [PMID: 23610614]
  91. Platelets. 2020;31(3):399-402 [PMID: 31146647]
  92. J Clin Invest. 2000 Aug;106(3):385-92 [PMID: 10930441]
  93. Blood Adv. 2019 Nov 26;3(22):3780-3817 [PMID: 31770441]
  94. Cell Mol Immunol. 2016 May;13(3):277-92 [PMID: 27041638]
  95. J Exp Med. 2020 Apr 6;217(4): [PMID: 31978220]

Grants

  1. R01 HL102035/NHLBI NIH HHS

Word Cloud

Created with Highcharts 10.0.0dPLTplateletplateletsKupffercellspotentialimmuneclearancecellVIIIPlateletssmallversatilebloodcriticalhemostasis/thrombosisLocalaccumulationknowncontributorproinflammationvariousdiseasestatesHoweveranti-inflammatory/immunosuppressivepoorlyexploreduncoveredunexpectedlydesialylateddPLTsdown-regulatedresponsesplatelet-associated-independentantigenchallengesUtilizingmultispectralphotoacoustictomographytrackedtraffickinggutvasculatureexclusivecell-mediatedliverprocessidentifiedsynergisticallydependentglycoproteinIbαhepaticAshwell-MorellreceptorMechanisticallypotentiatedsystemicimmunosuppressivestateincreasedanti-inflammatorycytokinescirculatingCD4regulatoryTabolishabledepletionLastclinicallyrelevantmodelhemophiliapresensitizationattenuatedanti-factorantibodyproductionfactorinfusiondesialylationcommonlyoccursdaily-agedactivatedfindingsopennewavenuestowardunderstandinghomeostasispotentiatetherapeuticengineeredtransfusionscontrollingautoimmunealloimmunediseasesDesialylatedPlateletClearanceLiverNovelMechanismSystemicImmunosuppression

Similar Articles

Cited By